Menu
Back to Advocacy
Therapeutics and Clinical Risk Management
- Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients
- The effect of diabetes on perioperative complications following spinal surgery: a meta-analysis
- Effects of dapagliflozin on serum uric acid levels in hospitalized type 2 diabetic patients with inadequate glycemic control: a randomized controlled trial
- Reevaluation and update on efficacy and safety of neostigmine for reversal of neuromuscular blockade
- Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy